spacer
home > ict > autumn 2009 > equipped for success
PUBLICATIONS
International Clinical Trials

Equipped for Success

 

Over recent years, many good articles have been written about outsourcing in clinical studies. Most of these refer to outsourcing of trials by pharma companies to clinical research organisations, and cover all aspects from cost benefit analysis, supplier selection process, scorecards, performance measurement and management of customer and supplier relationships. At the risk of being inundated with responses from readers advising me to the contrary, I cannot recollect reading any articles regarding outsourcing of a company’s medical equipment requirements for clinical studies to a single supplier.

In many ways, this is understandable, as initiation of an outsourcing project is often instigated by senior levels within a business such as board members and directors. For the majority of clinical trials, the total cost of medical equipment is a very low figure, often less than two per cent of the trial cost. For this reason, medical equipment will rarely appear on senior management’s radar unless it has been the cause of serious delays or caused impairment of the results of a trial.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

David Maughan is Managing Director of Medical Equipment Supplies and Management Ltd (MESM), a global supplier of medical equipment to the clinical trials industry. David is also a non-executive director of the Optare Group (bus manufacturer), board member of the Northwest Industrial Development Board and also of the North-west Automotive Alliance. David spent 30 years working in the automotive sector in various procurement roles, the most recent being 10 years as Purchasing Director of Bentley motor cars, part of the VW Group. During that time he was a member of the corporate sourcing committee for all group purchases.

spacer
David Maughan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Wool packaging firm’s green scheme goes ‘beyond recycling’

An award-winning company that has spent more than 10 years innovating in sustainable packaging has launched a scheme that it says goes ‘beyond recycling’ – by allowing the end user to return their packaging directly to them to be used again.
More info >>

White Papers

Pharmacovigilance and Risk Management Information in Centralised Applications in the EU

United BioSource Corporation (UBC)

Getting a new medication approved for the EU market through the centralised procedure can be complex and needs expertise. The new EU pharmacovigilance legislation (Good Vigilance Practice, GVP) is now in effect and applicants need to be fully compliant. It is critical to have a thorough understanding of the regulatory process and requirements, and the expectations with regards to the pharmacovigilance system and the risk management plan. Ensuring consistency and an appropriate level of detail in the documentation submitted as part of the approval process will help prevent unnecessary delays.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement